May 9 - Red Herring - The pace of mergers and acquisitions in the biotechnology industry is seen to continue at a torrid pace through 2007, said panelists at the Biotechnology Industry Organization conference in Boston on Wednesday.
The bullish forecast was issued after a recent Ernst & Young report found that US biotech deal values soared to $23 billion in 2006—an all time record—while high premiums drove the value of acquisitions to the second highest level in history. Read More.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment